Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis

Stockholm, November 8, 2021 - Intervacc AB (“Intervacc”) announces that the United States Patent and Trademark Office has granted an approval for Intervacc's patent application in the United States for a vaccine against Streptococcus suis infections. The U.S. Patent No. 11,155,585 relates to a vaccine based on recombinant fusion proteins where patent protection is effective until 2037. The bacterium Streptococcus suis (S. suis) can cause sepsis, arthritis and meningitis in pigs. S. suis infection is one of the most common bacterial causes of fatal infection in recently weaned pigs and is

Shipping the Critical Enabler in Global Transition, ABS Chairman, President and CEO Tells COP26

(GLASGOW) Shipping is the critical enabler in the world’s transition to low carbon operations and needs Government support to ensure it is at the front of the queue for next-generation fuels. That was the message from ABS Chairman, President and CEO, Christopher J. Wiernicki to delegates at the UN Framework Convention on Climate Change, COP26. “Governments will have a pretty significant role in this, but shipping is going to be the critical enabler. It is going to be shipping that will move the next generation of fuels from the centers of production to distribution hubs around the

NoHo Partners Plc’s Financial Reporting and Annual General Meeting in 2022

NoHo Partners Plc STOCK EXCHANGE RELEASE 8 November 2021 at 20:00NoHo Partners Plc’s Financial Reporting and Annual General Meeting in 2022NoHo Partners Plc will publish the 2021 financial statements bulletin on Thursday 17/02/2022 approximately at 8:15 am.NoHo Partners Plc’s 2021 financial statements and annual report will be published during week 11.The financial reports for 2022 will be published as follows:Interim report for January-March on Tuesday 10/05/2022 approximately at 8:15amHalf-year report for January-June on Tuesday 9/08/2022 approximately at 8:15amInterim

Terveystalo Plc: SHARE REPURCHASE 8.11.2021

Terveystalo Plc ANNOUNCEMENT  8.11.2021 Terveystalo Plc: SHARE REPURCHASE 8.11.2021 In the Helsinki Stock Exchange Trade date           8.11.2021Bourse trade         BuyShare                  TTALOAmount             9 634 SharesAverage price/ share    11,3643 EURTotal cost            109 483,67 EUR Terveystalo Plc now holds a total of 847 634 sharesincluding the shares repurchased on 8.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer

Oslo, Norway, 8 November 2021 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Pierre Dodion MD as Chief Medical Officer (CMO). Dr Dodion is taking over the role from Dr Christine Wilkinson Blanc, who is leaving the Company for personal reasons. Dr Wilkinson Blanc will remain with the Company until January 2022 to ensure a smooth transition. Dr Dodion joins Nordic Nanovector from Immunooncology Partners, a consultancy he founded to support biotech companies in clinical development, medical affairs and business development activities. In this role, he has acted as a

AR Waveguide Leader Dispelix Announces $33M Investment

Enabling Next-Gen Lightweight Smart Glasses and Augmented Reality DisplaysNovember 8th – Palo Alto, CA – Dispelix®, the technology leader for extremely lightweight single-layer waveguides and see-through displays for Augmented Reality(AR), today announced it has closed a $33M Series-B round led by Atlantic Bridge alongside new investors CCB Trust and Flashpoint. All existing investors including Lifeline Ventures, VTT Ventures, Finnish Industry Investment and 3M Ventures participated in this round, bringing the total funding to date to $50 million.  “Our patented see-through display

DIAN-TU selects lecanemab for clinical trial for dominantly inherited Alzheimer’s disease

Stockholm, November 8, 2021 - BioArctic AB:s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by the Washington University School of Medicine in St. Louis, has agreed with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to amend the clinical study (Tau NexGen) design to include a background anti-amyloid agent. The Tau NexGen clinical study was originally designed to focus on therapies that target tau. With increasing evidence from clinical studies showing that

Luleå University of Technology, Sweden, orders MDLab research unit from SolarSpring GmbH

Today, SolarSpring received an order for a MDLab research unit with custom set-up features from the Luleå University of Technology, Sweden. The system in the value of 54 k€ permits a broad spectrum of scientific investigations with membrane distillation.SolarSpring GmbH, a 100% subsidiary of Clean Industry Solutions Holding Europe AB, is a pioneer in the field of membrane distillation offering innovative waste- and drinking water treatment technology.The Luleå University of Technology, Sweden, requested a SolarSpring MDLab research unit that can function in both a Direct Contact Membrane

CORRECTION FOR ANNOUNCEMENT NO. 78 (QUANTITY): NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 80 - 8 NOVEMBER 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tlf.: 3315 0451

Business transacted at the extraordinary general meeting of Aquaporin A/S

Company announcement no. 22/2021  Today an extraordinary general meeting of Aquaporin A/S was held at which the following resolutions were approved in accordance with the notice to convene the extraordinary general meeting: · Anupam Bhargava was elected as new member to the Board of Directors; and · Jianlong Zhuang was elected as new member to the Board of Directors. As described in the notice to convene the extraordinary general meeting, Jianwen Cai has resigned from the Board of Directors in connection with the election of Jianlong Zhuang. For further information, please

Introducing the datAshur SD: The world’s first and only PIN authenticated hardware encrypted USB flash drive with removable iStorage microSD Cards.

iStorage, the award winning and trusted global leader of PIN authenticated, hardware encrypted data storage and cloud encryption solutions, is delighted to unveil the future of data security with the launch of yet another ground-breaking product.The datAshur SD is the world’s first and only PIN authenticated hardware encrypted USB flash drive to incorporate removable microSD Cards.  Rather than the classic USB flash-drive design of incorporating fixed memory, the brand new datAshur SD is uniquely designed with an integrated microSD Card slot which enables consumers to use one drive with

Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam

First Patient Dosed in Study Evaluating Mitazalimab in Combination with Cancer Vaccine for Patients with Pancreatic Cancer   Lund, Sweden, November 8, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the initiation of a proof-of-concept Phase Ib clinical trial to assess the safety and efficacy of mitazalimab in combination with MesoPher, an experimental dendritic cell vaccine, in patients with pancreatic cancer. The trial will be led by investigators at Erasmus MC University Medical Center Rotterdam, The Netherlands.   The first patient has been dosed in the

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 08.11.2021

United Bankers Corporation NOTIFICATION 08.11.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 08.11.2021 Date 08.11.2021Exchange transaction BuyShare class UNITEDAmount 111Average price/share 13.7000 EURHighest price/share 13.7000 EURLowest price/share 13.7000 EURTotal price 1,520.70 EUR The shares held by United Bankers Corporation on 08.11.2021: UNITED 51,340 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Entra – Launch of mandatory offer to acquire all shares in Entra ASA

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFULOslo, Norway – 8 November 2021 Reference is made to the stock exchange announcement by Entra ASA (the “Company”) on 12 October 2021, where it was informed that Fastighets AB Balder (“Balder” or the “Offeror”) had acquired 610,059 shares in the Company, resulting in an aggregate holding of 61,320,119 shares, equalling 33.67 % of the shares and votes in the Company, thereby

Crunchfish announces the last day of trading in BTU and the first trading day in warrants

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Crunchfish AB (publ)’s (“Crunchfish” or the “Company”) rights issue of units of approximately SEK 64.4 million (the “Rights Issue”) has now been registered with the Swedish Companies Registration Office. The last day of trading in paid

Internet Vikings raises the game for Playstar Casino as they prepare to move into Pennsylvania

Internet Vikings is excited to announce that they will continue to support Playstar Casino’s expansion into the U.S. throughout 2022. Global hosting services provider has recently confirmed that they have just reinforced their partnership with the international online casino provider by entering another long-term agreement in yet another state - Pennsylvania, where Playstar is expected to commence its operations in Q1 2022. The Swedish-based casino has an incredible and ambitious start mapped out for their U.S. expansion with New Jersey being the first state on American soil in

Pexip acquires Skedify to accelerate the delivery of video enabled business-to-consumer applications

Oslo, Norway, 8 November, 2021 - Pexip Holding ASA (“Pexip”, Oslo Børs Ticker: PEXIP), a leading enterprise video communication platform provider, today announced the acquisition of Skedify, a Belgium based Software-as-a-Service customer engagement solution.The utilization of video as a core communication tool has accelerated over the last few years, not only for internal meetings in organizations, but also increasingly in customer-facing applications across industries. Many organizations in sectors such as retail and financial services are opening their eyes to the huge potential video

The exercise price for the warrants of series TO1 in Realfiction Holding AB has been determined to SEK 11.46 and the exercise period starts tomorrow, 9 November 2021

Not for release, publication or distribution in whole or in part, directly or indirectly, in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea or any other jurisdiction where such release, publication or distribution would be unlawful or would require registration or any other measures. Please refer to important information at the end of the press release. Realfiction Holding AB (“Realfiction” or the “Company”) completed a directed issue of units during the fourth quarter of 2020. One (1) unit consisted of five (5) newly issued shares

#21-367 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Amendment of SHIP2FAIR Grant Agreement

Due to unforeseen parameters regarding a demonstration site assigned to Industrial Solar, amendments will be made in relation to the grant agreement for the Horizon 2020 project SHIP2FAIR. Thus, no second demonstration system with Industrial Solar's technology will be built, which might result in a budget reduction of up to 500 k€.Industrial Solar GmbH, a 100% subsidiary of CISH AB, is member of the consortium of the project SHIP2FAIR supported by the European Commission within the Horizon 2020 program. The project aims to foster the integration of solar heat in industrial processes of the

Bulletin from the extraordinary general meeting in Alligator Bioscience AB

Today, on 8 November 2021, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows below. In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the meeting was held only by advance voting (postal vote) in accordance with temporary legislation.   Resolution on amendment of the Articles of Association The meeting resolved in accordance with the proposal from the board of directors to amend §§ 4-5 of the Articles of Association so that the limits for the share capital and the number

Presentation of K-Fastigheter’s results for January–September 2021

K-Fast Holding AB (“K-Fastigheter”) announces its interim results for January–September 2021 on 12 November 2021 at 8:00 a.m. CET. The report will be presented in a pre-recorded audio cast at 8:30 a.m. CET the same day.Jacob Karlsson, CEO, and Martin Larsson, CFO, will present the earnings and operations. The presentation materials (slides + audio) will be available at www.k-fastigheter.com/en/for-investors/presentations. The presentation will be held in Swedish with presentation materials in English. Questions may be addressed in writing to ir@k-fastigheter.se with answers being

Nurminen Logistics expands the range of services of the Forwarding business line to support the company’s international growth

Nurminen Logistics Plc                            Stock Exhange Release 8 November 2021, at 5.32 pm The service portfolio of Nurminen Logistics’ Forwarding business line will be expanded to match the continuous growth in the volumes of railway traffic between Asia and Europe and the increasing demand for multimodal transport, especially in the Nordic and European markets. Nurminen Logistics has experience as the forwarder of customs and transport documents of different freight transport forms, offices at border crossing points important to the traffic flows and strong expertise in

There are no items matching the current filter
There are no more items matching the current filter
Back to top